Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | ARQTArcutis Biotherapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $376.07M |
| Revenue, yoy | +91.3% |
| Net income | $16.14M |
| Net income, yoy | +88.5% |
| Net margin | -4.3% |
| Free cash flow | $6.31M |
| FCF margin | -1.7% |
| EPS, diluted | $0.13 |
Add another company.